US 12,215,123 B2
Cordycepin-based derivatized compound with anti-tumor effect
Hanjie Ying, Nanjing (CN); Tao Shen, Nanjing (CN); Chenglun Tang, Nanjing (CN); Dong Liu, Nanjing (CN); Yong Chen, Nanjing (CN); Chenjie Zhu, Nanjing (CN); Pengpeng Yang, Nanjing (CN); and Wei Zhuang, Nanjing (CN)
Assigned to NANJING TECH UNIVERSITY, Nanjing (CN)
Filed by NANJING TECH UNIVERSITY, Nanjing (CN)
Filed on Nov. 9, 2023, as Appl. No. 18/505,822.
Application 18/505,822 is a continuation of application No. PCT/CN2023/099859, filed on Jun. 13, 2023.
Claims priority of application No. 202210818492.X (CN), filed on Jul. 12, 2022.
Prior Publication US 2024/0116976 A1, Apr. 11, 2024
Int. Cl. C07H 19/20 (2006.01); A61P 35/00 (2006.01); C07H 19/173 (2006.01)
CPC C07H 19/20 (2013.01) [A61P 35/00 (2018.01); C07H 19/173 (2013.01)] 8 Claims
 
1. A cordycepin derivative is

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.